These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 23269742)

  • 21. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.
    Ladhani SN; Collins S; Djennad A; Sheppard CL; Borrow R; Fry NK; Andrews NJ; Miller E; Ramsay ME
    Lancet Infect Dis; 2018 Apr; 18(4):441-451. PubMed ID: 29395999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
    van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
    PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.
    Ladhani SN; Slack MP; Andrews NJ; Waight PA; Borrow R; Miller E
    Emerg Infect Dis; 2013 Jan; 19(1):61-8. PubMed ID: 23259937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.
    Melegaro A; Choi YH; George R; Edmunds WJ; Miller E; Gay NJ
    BMC Infect Dis; 2010 Apr; 10():90. PubMed ID: 20377886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
    J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.
    Stockmann C; Ampofo K; Byington CL; Filloux F; Hersh AL; Blaschke AJ; Cowan P; Korgenski K; Mason EO; Pavia AT
    Pediatrics; 2013 Sep; 132(3):421-8. PubMed ID: 23979090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.
    Olarte L; Ampofo K; Stockmann C; Mason EO; Daly JA; Pavia AT; Byington CL
    Pediatrics; 2013 Jul; 132(1):e17-24. PubMed ID: 23733800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Amin-Chowdhury Z; Groves N; Sheppard CL; Litt D; Fry NK; Andrews N; Ladhani SN
    Vaccine; 2021 Apr; 39(14):1997-2004. PubMed ID: 33715901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.
    van der Linden M; Perniciaro S; Imöhl M
    BMC Infect Dis; 2015 May; 15():207. PubMed ID: 25940580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
    Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
    Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006.
    Trotter CL; Waight P; Andrews NJ; Slack M; Efstratiou A; George R; Miller E
    J Infect; 2010 Mar; 60(3):200-8. PubMed ID: 20035785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.
    Galanis I; Lindstrand A; Darenberg J; Browall S; Nannapaneni P; Sjöström K; Morfeldt E; Naucler P; Blennow M; Örtqvist Å; Henriques-Normark B
    Eur Respir J; 2016 Apr; 47(4):1208-18. PubMed ID: 26797033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
    Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Oligbu G; Collins S; Andrews N; Sheppard CL; Fry NK; Slack MPE; Borrow R; Ladhani SN
    Clin Infect Dis; 2017 Oct; 65(7):1191-1198. PubMed ID: 29309553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylogeography and resistome of pneumococcal meningitis in West Africa before and after vaccine introduction.
    Senghore M; Tientcheu PE; Worwui AK; Jarju S; Okoi C; Suso SMS; Foster-Nyarko E; Ebruke C; Sonko M; Kourna MH; Agossou J; Tsolenyanu E; Renner LA; Ansong D; Sanneh B; Cisse CB; Boula A; Miwanda B; Lo SW; Gladstone RA; Schwartz S; Hawkins P; McGee L; Klugman KP; Breiman RF; Bentley SD; Mwenda JM; Kwambana-Adams BA; Antonio M
    Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34328412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine.
    Levy C; Varon E; Bingen E; Lécuyer A; Boucherat M; Cohen R;
    Pediatr Infect Dis J; 2011 Feb; 30(2):168-70. PubMed ID: 21298818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.